Four spontaneous, single-step mutants of Escherichia coli K-12 resistant to low levels of the cephalosporin 3-quinolone ester Ro 23-9424 were isolated at a frequency of 10 ؊10 to 10 ؊11 mutants per CFU plated. The mutants were cross-resistant to both cephalosporin (cefotaxime) and quinolone (fleroxacin) components. Accordingly, they had altered porins and replicative DNA biosynthesis resistant to fleroxacin. There was no increase in ␤-lactamase activity when tested with nitrocephin, and the penicillin-binding protein profiles were normal.
3 to mid-logarithmic phase (A 660 of 0.4) or stationary phase (cultures grown overnight). Cells were harvested, washed, and concentrated to 10 10 CFU/ml in SM buffer (0.1 M NaCl, 17 mM MgSO 4 , 5.0 mM Tris-HCl [pH 7.5], 0.01% gelatin). Aliquots (100 l) were spread onto nutrient agar plates containing 0.2 or 0.4 g of Ro 23-9424 per ml (4ϫ and 8ϫ MIC, respectively) and incubated for 48 h at 37ЊC. Resistance frequency was obtained as the number of Ro 23-9424-resistant mutants divided by the number of CFU plated. Mutants were confirmed as E. coli JF568 derivatives with Enterotube II kits from Roche Diagnostic Systems (Nutley, N.J.).
The susceptibilities of the mutant strains to OmpF-or OmpC-specific phages were determined as an indicator of porin expression. Mid-logarithmic-phase cells (200 l) were mixed with 2.0 ml of molten soft agar (0.5% agar) and poured onto the surface of a nutrient agar (1.5% agar) plate. After hardening, 5 l of SM buffer or bacteriophage in SM buffer (K20, OmpF-specific; PA2, OmpC-specific) (15) were spotted directly onto the agar surface and allowed to soak into the agar. Plates were incubated at 37ЊC, and the number of PFU was counted after 18 h. The plaquing efficiency was calculated by dividing the number of PFU per milliliter obtained with the mutant strains by the number of PFU per milliliter obtained with strain JF568.
Outer membrane proteins were prepared as described previously (11) and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis in 8 M urea by the method of Lundrigan and Earhart (10). (2) and norfloxacin (9) but substantially lower than those reported for the older quinolones nalidixic and oxolinic acid (16) and for ␤-lactams (3). Strains resistant to Ro 23-9424 were cross-resistant to both quinolone and ␤-lactam antibiotics (Table 2 ). In contrast, E. coli mutants resistant to fleroxacin were not necessarily crossresistant to ␤-lactam antibiotics (2), and E. coli mutants resistant to ceftriaxone, but not fleroxacin, showed little crossresistance to Ro 23-9424 (5, 6).
All four strains had altered porins, as determined by outer membrane protein profiles (data not shown) and susceptibilities to porin-specific phages (Table 3) . Three strains had altered OmpF protein, and one strain had altered OmpF and OmpC proteins. Replicative DNA biosynthesis in the four strains was resistant to fleroxacin and in two strains (JSC120 and JSC122) was resistant to norfloxacin but not to ciprofloxacin ( Table 4) . None of the strains had altered PBP profiles (Fig. 1) or increased ␤-lactamase activity when tested with the chromogenic cephalosporin nitrocephin (data not shown). Thus, low resistance to Ro 23-9424 appears to result from the combined effects of decreased outer membrane permeability and altered DNA gyrase.
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